Physician profile
Christyn Marshall
NPI 1376958405
$3,335.87
in general payments reported to CMS, 2019-2025
26 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $357 · 2021: $1,444 · 2022: $374 · 2023: $50.09 · 2024: $254 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $1,243.97 | 2021 | |
| Bioventus LLC | $369.76 | 2019-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $237.68 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $226.93 | 2020-2021 | |
| Amgen INC. | $150.34 | 2024-2025 | Krystexxa |
| Exactech, INC. | $137.41 | 2025 | |
| Horizon Therapeutics Plc | $124.98 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $123.17 | 2020-2021 | |
| Integra Lifesciences Corporation | $105.35 | 2019-2020 | |
| Mimedx Group, INC. | $104.30 | 2024-2025 | |
| Alfasigma USA, INC. | $66.18 | 2021-2022 | |
| Paragon 28, INC. | $62.67 | 2021-2024 | Mtp |
| Orthofix Medical, INC. | $55.46 | 2021-2025 | Physio-Stim |
| Anika Therapeutics, INC. | $46.02 | 2022 | |
| Smith+Nephew, INC. | $45.41 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Extremity Systems, LLC | $42.81 | 2019-2020 | |
| Sanara Medtech INC. | $37.28 | 2022 | |
| Stryker Corporation | $21.67 | 2024 | Augment Injectable |
| Medtronic, INC. | $20.79 | 2024 | Venaseal |
| Depuy Synthes Sales INC. | $19.67 | 2024 | |
| Paratek Pharmaceuticals, INC. | $19.11 | 2021 | |
| Organogenesis INC. | $17.50 | 2024 | Puraply Am |
| Terumo Bct, INC. | $17.47 | 2020 | |
| Stimwave Technologies Incorporated | $14.96 | 2021 | |
| Convatec INC. | $12.60 | 2022 | |
| Arthrosurface Incorporated | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christyn Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.